Other researchers and we have demonstrated that the expression of LOXL4 is upregulated in several human cancers, including head and neck squamous cell carcinoma (HNSCC) [47], laryngeal squamous cell carcinoma [49], and gastric cancer [11]. This evidence concerns the gene LOXL4 and head and neck squamous cell carcinoma.